{
  "retracted": false,
  "timestamp": 1476662400000,
  "updates": [
    {
      "timestamp": 1585253818516,
      "identifier": {
        "doi": "10.1080/02652048.2016.1231656"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1080/02652048.2016.1222006"
  },
  "publisher": "Informa UK Limited",
  "title": "Correction to: Erukula and Chatterjee, Factors influencing the fabrication of albumin-bound drug nanoparticles (ABDns): Part II. Albumin-bound carbamazepine nanoparticles (ABCns)"
}
